Akebia Therapeutics, Inc.AKBANASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 295 | 212↓28.2% | 292↑38.2% | 195↓33.5% | 160↓17.7% |
| Gross Profit | 231 | 130↓43.6% | 270↑107.4% | 120↓55.4% | 97↓19.5% |
| Operating Income | -378 | -265↑30.0% | -81↑69.5% | -46↑42.7% | -50↓9.1% |
| Net Income | -385 | -282↑26.7% | -94↑66.6% | -52↑44.9% | -69↓33.7% |
| EBITDA | -140 | -190↓35.8% | 3↑101.6% | -8↓370.5% | -14↓66.0% |
| EPS Diluted | -2.53 | -1.48↑41.5% | -0.58↑60.8% | -0.28↑51.7% | -0.33↓17.9% |